Viking Global Investors
ABMD

Viking Global Investors’s Abiomed Inc ABMD Stock Holding History

Viking Global Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-82,572
Closed -$29.7M – 122
2021
Q4 		$29.7M Buy
+82,572
New +$27.9M 0.09% 99

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Viking Global Investors's ABMD Position: Q1 2022 in Review

Viking Global Investors sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 82,572 shares — an estimated $29.7M sold.

Viking Global Investors first reported a position in ABMD in Q4 2021 and held it in 1 quarter. The position peaked at $29.7M in Q4 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Viking Global Investors reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Viking Global Investors sold 82,572 Abiomed Inc shares in Q1 2022, an estimated $29.7M.
  • Viking Global Investors first reported a position in Abiomed Inc in Q4 2021 and held it in 1 quarter.
  • Viking Global Investors's Abiomed Inc position peaked at $29.7M in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.